Market Overview

The Global Influenza Diagnostics Market was valued at USD 1,253.7 million in 2023 and is expected to reach USD 2,303.4 million by 2031 while growing at a CAGR of 7.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global influenza diagnostics market growth. Influenza diagnostics involve employing tests and procedures to identify influenza virus infections in individuals exhibiting symptoms of influenza-like illness (ILI), including fever, cough, sore throat, body aches, and fatigue. Rapid and precise diagnosis of influenza plays a critical role in ensuring proper patient care, implementing infection control measures, and conducting public health surveillance.

Continuous advancements in diagnostic technologies such as nucleic acid amplification tests (NAATs), rapid antigen tests, and molecular assays, along with government initiatives and public health programs, propel the influenza diagnostics market forward. Nevertheless, regulatory challenges, compliance burdens, and cost constraints, including reimbursement limitations, could hinder market growth.

Furthermore, the global influenza diagnostics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Test Type Analysis

The Global Influenza Diagnostics Market is segmented among Traditional Diagnostic Tests, and Molecular Diagnostic Assays, based on Test Type. In 2023, Traditional Diagnostic Test accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By End User Analysis

The Global Influenza Diagnostics Market is segmented among Hospital, Laboratories, and Other End Users, based on Type. In 2023, Laboratories  accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Influenza Diagnostics Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Abbott Laboratories, Becton, Dickinson and Company, Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, and Thermo Fisher Scientific Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Influenza Diagnostics Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Influenza Diagnostics Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Influenza Diagnostics Market Segmentation, By Test Type

• Global Influenza Diagnostics Market Share Analysis, By Test Type

• Global Influenza Diagnostics Market Growth Analysis, By Test Type

• Global Influenza Diagnostics Market Trends, By Test Type

o Traditional Diagnostic Test

Ø Rapid Influenza Diagnostic Test

Ø Viral Culture

Ø Direct Fluorescent Antibody (DFA) Test

Ø Serological Assay

o Molecular Diagnostic Assay

Ø RT-PCR

Ø Nucleic Acid Sequence-based Amplification (NASBA) Test

Ø Loop-mediated Isothermal Amplification-based Assay

Ø Simple Amplification-based Assay

Ø Other Molecular Diagnostic Assays

6. Global Influenza Diagnostics Market Segmentation, By End User

• Global Influenza Diagnostics Market Share Analysis, By End User

• Global Influenza Diagnostics Market Growth Analysis, By End User

• Global Influenza Diagnostics Market Trends, By End User

o Hospital

o Laboratories

o Other End Users

7. Global Influenza Diagnostics Market Segmentation, By Region

• Global Influenza Diagnostics Market Share Analysis, By Region

• Global Influenza Diagnostics Market Growth Analysis, By Region

• Global Influenza Diagnostics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Becton, Dickinson and Company

• Coris BioConcept

• DiaSorin SpA

• F. Hoffmann-La Roche Ltd

• Meridian Bioscience Inc.

• Quidel Corporation

• Sekisui Diagnostics

• Thermo Fisher Scientific Inc.

*Similar analysis will be provided for each company listed above.